ERBB2 and breast carcinoma: Only one study has reported on the role of SK1 in vivo models of breast cancer where it was shown that SK1 deficiency decreases breast tumor growth in MMTV-neu transgenic induced breast cancer, but analysis of metastasis was not documented in that study [23].